Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ClinicalTrials.gov 24,857 recruiting now free trial finder

Find a clinical trial that's recruiting now

Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.

24,857
trials recruiting now
14%
of all US trials open to enrollment
52
states with recruiting sites

A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.

Showing the 40 largest recruiting trials by target enrollment in Oklahoma. Use the search field to focus on a condition or drug.

Recruiting 100,000 participants

Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility

St. Jude Children's Research Hospital

NCT01354002

Recruiting 14,000 participants

Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

Baylor Research Institute

NCT01904851

Recruiting 10,000 participants

Innovations in Genicular Outcomes Registry

Pacira Pharmaceuticals

NCT05495334

Recruiting NA 8,000 participants

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

M.D. Anderson Cancer Center

NCT00539162

Recruiting Phase 3 5,200 participants

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Colorado Prevention Center

NCT06008197

Recruiting 5,000 participants

Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

Massachusetts General Hospital

NCT01696721

Recruiting 3,600 participants

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

George Washington University

NCT06525259

Recruiting Phase 4 3,500 participants

International Care Bundle Evaluation in Cerebral Hemorrhage Research

Region Skane

NCT06429332

Recruiting NA 3,266 participants

Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)

Minneapolis Heart Institute Foundation

NCT04077762

Recruiting 2,946 participants

Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)

Exactech

NCT05849961

Recruiting 2,000 participants

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

Elephas

NCT07327489

Recruiting Phase 3 1,800 participants

Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera

NCT07284875

Recruiting NA 1,605 participants

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

Concept Medical

NCT06271590

Recruiting 1,500 participants

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

Bristol-Myers Squibb

NCT07379827

Recruiting Phase 3 1,220 participants

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

AstraZeneca

NCT06921785

Recruiting Phase 3 1,200 participants

Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Kailera

NCT07284979

Recruiting NA 1,040 participants

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

University of Calgary

NCT05219110

Recruiting NA 1,035 participants

Pain and Opioid Management in Older Adults

University of Oklahoma

NCT05037682

Recruiting NA 1,024 participants

iAmHealthy Clinical Practice Guideline (CPG)

University of Kansas Medical Center

NCT06888011

Recruiting 1,000 participants

International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry

SCAD Alliance

NCT04496687

Recruiting NA 1,000 participants

A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD

Cleerly

NCT06713239

Recruiting NA 947 participants

The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals

Mayo Clinic

NCT06087224

Recruiting Phase 2 901 participants

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Sanofi

NCT05769777

Recruiting Phase 3 900 participants

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Hoffmann-La Roche

NCT07174310

Recruiting Phase 2 900 participants

Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma.

Sanofi

NCT06609239

Recruiting Phase 1 890 participants

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Regeneron Pharmaceuticals

NCT03564340

Recruiting Phase 4 850 participants

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

St. Jude Children's Research Hospital

NCT06289673

Recruiting Phase 4 832 participants

A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations

ModernaTX

NCT07089706

Recruiting NA 828 participants

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

Indiana University

NCT05124808

Recruiting NA 800 participants

Physica System Total Knee Replacement Registry Study

Limacorporate S.p.a

NCT03048201

Recruiting Phase 2 787 participants

Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0

University of Oklahoma

NCT06488781

Recruiting Phase 3 770 participants

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Merck Sharp & Dohme

NCT06824467

Recruiting Phase 1 764 participants

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Genmab

NCT05579366

Recruiting Phase 3 750 participants

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis

Janssen Research & Development

NCT06807424

Recruiting NA 750 participants

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)

National Cancer Institute (NCI)

NCT06498661

Recruiting Phase 3 750 participants

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Amgen

NCT07213674

Recruiting Phase 2 740 participants

Optimizing Reperfusion to Improve Outcomes and Neurologic Function

Corxel Pharmaceuticals

NCT06990867

Recruiting 700 participants

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

Hospital for Special Surgery, New York

NCT00198068

Recruiting Phase 3 690 participants

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Reviva Pharmaceuticals

NCT05184335

Recruiting Phase 3 620 participants

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

Axsome Therapeutics

NCT07398417

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.

Verify with NIH →